General Information of Drug (ID: DMC9Z45)

Drug Name
4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol Drug Info
Synonyms
CHEMBL268881; NSC622468; 4-(4-Isopropyl-2-morpholinyl)-1,2-benzenediol hydrochloride; AC1L7GLH; AC1Q7ACF; 4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol; BDBM50000499; AKOS022660109; NCI60_006589; 4-(4-isopropylmorpholin-2-yl)benzene-1,2-diol; 4-(4-propan-2-ylmorpholin-2-yl)benzene-1,2-diol; 1,2-benzenediol, 4-[4-(1-methylethyl)-2-morpholinyl]-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
360400
TTD Drug ID
DMC9Z45

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adrenergic receptor alpha-1A (ADRA1A) TTNGILX ADA1A_HUMAN Inhibitor [1]
Adrenergic receptor alpha-1B (ADRA1B) TTBRKXS ADA1B_HUMAN Inhibitor [1]
Adrenergic receptor alpha-1D (ADRA1D) TT34BHT ADA1D_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Adrenergic receptor alpha-1A (ADRA1A) DTT ADRA1A 3.154 3.853 4.129 2.963
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Adrenergic receptor alpha-1A (ADRA1A) DTT ADRA1A 9.43E-01 -0.03 -0.25
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of alpha- and beta-adrenergic rece... J Med Chem. 1992 Mar 20;35(6):1009-18.